Imaging atherosclerosis and vulnerable plaque

Mehran M. Sadeghi, David K. Glover, Gregory M. Lanza, Zahi A. Fayad, Lynne L. Johnson

Research output: Contribution to journalReview articlepeer-review

77 Scopus citations


Identifying patients at high risk for an acute cardiovascular event such as myocardial infarction or stroke and assessing the total atherosclerotic burden are clinically important. Currently available imaging modalities can delineate vascular wall anatomy and, with novel probes, target biologic processes important in plaque evolution and plaque stability. Expansion of the vessel wall involving remodeling of the extracellular matrix can be imaged, as can angiogenesis of the vasa vasorum, plaque inflammation, and fibrin deposits on early nonocclusive vascular thrombosis. Several imaging platforms are available for targeted vascular imaging to acquire information on both anatomy and pathobiology in the same imaging session using either hybrid technology (nuclear combined with CT) or MRI combined with novel probes targeting processes identified by molecular biology to be of importance. This article will discuss the current state of the art of these modalities and challenges to clinical translation.

Original languageEnglish
Pages (from-to)51S-65S
JournalJournal of Nuclear Medicine
Issue numberSUPPL.1
StatePublished - 2010


  • Atherosclerosis
  • Clinical cardiology
  • Molecular imaging
  • Plaque
  • Vascular
  • Vascular remodeling


Dive into the research topics of 'Imaging atherosclerosis and vulnerable plaque'. Together they form a unique fingerprint.

Cite this